Macrothrombocytopenia of Takenouchi-Kosaki syndrome is ameliorated by CDC42 specific- and lipidation inhibitors in MEG-01 cells. The gene discussed is CDC42; the disease is macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome.